Prevention of Deep Vein Thrombosis after Hip Replacement

André Planès; Meyer M. Samama; Anthonie W. A. Lensing; Harry R. Büller; Jeanne Barre; Nicole Vochelle; Bertrand Beau

doi:10.1055/s-0037-1614411

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1999; 81(01): 22-25
DOI: 10.1055/s-0037-1614411

Review Article

Schattauer GmbH

Prevention of Deep Vein Thrombosis after Hip Replacement

Comparison between Two Low-molecular-weight Heparins, Tinzaparin and Enoxaparin

André Planès

¹From Clinique Radio-Chirurgicale du Mail, La Rochelle, France

,

Meyer M. Samama

²From Hôpital Hôtel Dieu, Paris, France,

,

Anthonie W. A. Lensing

³From Academic Medical Center, Amsterdam, The Netherlands;

,

Harry R. Büller

³From Academic Medical Center, Amsterdam, The Netherlands;

,

Jeanne Barre

⁴From Hôpital Robert Debré, Reims, France

,

Nicole Vochelle

⁴From Hôpital Robert Debré, Reims, France

,

Bertrand Beau

⁵From LEO Laboratories, Saint Quentin en Yvelines, France

› Institutsangaben

Abstract

Volltext

als PDF herunterladen

Referenzen

References
1 Hirsh J, Levine MN. Low-molecular-weight heparin. Blood 1992; 79 (01) 1-17.
2 Barrowcliffe TW, Johnson EA, Thomas DP. Low molecular weight heparin. Eds John Wiley, Chichester; 1992
3 Nurmohamed MT, Rosendaal FR, Büller HR. et al Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 1992; 340: 152-6.
4 Leizorovicz A, Haugh MC, Chapuis FR. et al Low-molecular-weight heparin in prevention of perioperative thrombosis. BMJ 1992; 305: 913-20.
5 Jorgensen LN, Wille-Jorgensen P, Hauch O. Prophylaxis of postoperative thromboembolism with low molecular weight heparins. Br J Surg 1993; 80: 689-704.
6 Mätzsch T, Bergqvist D, Fredin H. et al Comparison of the thromboprophylactic effect of a low-molecular-weight heparin versus dextran in total hip replacement. Thromb Haemorrh Disorders 1991; 3 (01) 25-9.
7 Lassen MR, Borris LC, Christiansen HM. et al Prevention of thromboembolism in 190 hip arthroplasties. Comparison of LMW heparin and placebo. Acta Orthop Scand 1991; 62 (01) 33-8.
8 Hull R, Raskob G, Pineo G. et al A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 1993; 329: 1370-6.
9 Planes A, Vochelle N, Mazas F. et al Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low-molecular-weight heparin in patients undergoing total hip replacement. Thromb Haemost 1988; 60: 407-10.
10 The Danish Enoxaparin Study Group. Low-molecular-weight heparin (Enoxaparin) vs Dextran 70: the prevention of postoperative deep vein thrombosis after total hip replacement. Arch Intern Med 1991; 151: 1621-4.
11 Planes A, Vochelle N, Fagola M. et al. Prevention of deep vein thrombosis after total hip replacement. the effect of low-molecular-weight heparin with spinal and general anaesthesia. J Bone Joint Surg 1991; 73: B418-22.
12 Spiro TE, Johnson GJ, Christie MJ. et al Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Ann Intern Med 1994; 121 (02) 81-9.
13 Planes A. Comparison of antithrombotic efficacy and haemorrhagic side-effects of Clivarin versus enoxaparin in patients undergoing total hip replacement surgery. Blood Coagul Fibrinolysis 1993; 4 (Suppl. 01) suppl S33-5.
14 Eriksson I B, Wille-Jorgensen P, Kälebo P. et al. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med 1997; 337: 1329-35.
15 Elalamy I, Potevin F, Lecrubier C. et al A fatal low-molecular-weight heparin associated thrombocytopenia after hip surgery: possible usefulness of PF4-heparin Elisa test. Blood Coagul and Fibrinolysis 1996; 7: 665-71.
16 Bounameaux H, Prins TR, Schmitt HE. et al. Venography of the lower limbs. Pitfalls of the diagnostic standard. Invest Radiol 1992; 27: 1009-11.
17 Lensing AWA, Büller HR, Prandoni P. et al. Contrast venography, the gold standard for the diagnosis of deep-vein thrombosis: improvement in observer agreement. Thromb Haemost 1992; 67: 8-12.
18 Wille-Jorgensen P, Borris L, Jorgensen N. et al. Phlebography as the gold standard in thromboprophylactic studies? A multicenter interobserver variation study. Acta Radiologica 1992; 33: 24-8.
19 Couson F, Bounameaux C, Didier D. et al. Influence of variability of interpretation of contrast venography for screening of postoperative deep venous thrombosis on the results of a thromboprophylactic study. Thromb Haemost 1993; 70 (04) 573-5.
20 Warkentin TE, Levine MN, Hirsh J. et al Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-5.
21 Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards a consensus. Thromb Haemost 1998; 79: 1-7.